Simulations Plus, Inc. (NASDAQ:SLP) Files An 8-K Financial Statements and ExhibitsItem 9.01
(d)Exhibits
| 99.1 | Press release issued on July 10, 2017. |
| 99.2 | PowerPoint presentation at the Investor Conference Call on July 10, 2017. |
SIMULATIONS PLUS INC ExhibitEX-99.1 2 simulations_8k-ex9901.htm PRESS RELEASE Exhibit 99.1 For Further Information: Simulations Plus,…To view the full exhibit click here
About Simulations Plus, Inc. (NASDAQ:SLP)
Simulations Plus, Inc. (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour. MedChem Designer includes a small set of ADMET Predictor property predictions, allowing the chemist to modify molecular structures. MedChem Studio is a tool for medicinal and computational chemists for both data mining and for designing new drug-like molecules. DDDPlus simulates in-vitro laboratory experiments used to measure the rate of dissolution of the drug. GastroPlus simulates the absorption, pharmacokinetics, and pharmacodynamics of drugs.
